O-GlcNAc transferase Antibodies

Santa Cruz Biotechnology features a diverse variety of O-GlcNAc transferase monoclonal antibodies for research focused on O-GlcNAcylation in cellular processes. O-GlcNAc transferase Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). O-GlcNAc transferase is an essential enzyme responsible for adding O-GlcNAc moieties to serine and threonine residues on nuclear and cytoplasmic proteins, influencing numerous cellular functions such as signal transduction, transcription, and stress responses. The regulation of O-GlcNAcylation plays a fundamental role in maintaining cellular homeostasis and has been linked to various diseases, including cancer and neurodegenerative disorders. Understanding O-GlcNAc transferase activity provides valuable insights into cellular signaling pathways and disease mechanisms. Studying O-GlcNAc transferase helps reveal its role in normal physiological processes and pathological conditions. Research utilizing O-GlcNAc transferase monoclonal antibodies contributes to advancing knowledge in cellular biology and disease treatment strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful discoveries in O-GlcNAcylation research and its impact on human health.